{
  "annotationGroups" : [ {
    "@id" : "https://pharmgkb.org/dosingGuidelineAnnotationGroup/PA166244203",
    "@context" : "https://api.pharmgkb.org/jsonld/dosingGuidelineAnnotationGroup.jsonld",
    "objCls" : "Dosing Guideline Annotation Group",
    "id" : "PA166244203",
    "name" : "Activity Score 2",
    "activityScore" : {
      "id" : 1451446764,
      "html" : "<p>2</p>\n",
      "version" : 0
    },
    "genePhenotypes" : [ "DPYD:Normal function/Normal function" ],
    "guideline" : {
      "@id" : "https://pharmgkb.org/guidelineAnnotation/PA166222801",
      "@context" : "https://api.pharmgkb.org/jsonld/guidelineAnnotation.jsonld",
      "objCls" : "Guideline Annotation",
      "id" : "PA166222801",
      "name" : "Annotation of DPWG Guideline for flucytosine and DPYD",
      "version" : 5
    },
    "implications" : {
      "id" : 1451446765,
      "html" : "<p>The guideline does not provide a description of the impact of a DPYD activity score of 2 on flucytosine.</p>\n",
      "version" : 0
    },
    "phenotype" : {
      "id" : 1451446766,
      "html" : "<p>Carrier of no variants associated with either reduced functionality or fully dysfunctional DPD activity.</p>\n",
      "version" : 0
    },
    "recommendation" : {
      "id" : 1451446767,
      "html" : "<p>The guideline does not provide a recommendation for flucytosine in patients with a DPYD activity score of 2.</p>\n",
      "version" : 0
    },
    "rxChangeStatus" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/rxChange/rxChange:1448602495",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 1448602495,
      "parents" : [ ],
      "resource" : "Prescribing Change",
      "term" : "No",
      "termId" : "rxChange:1448602495",
      "version" : 0
    },
    "strength" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 981501929,
      "description" : "Not Applicable",
      "parents" : [ ],
      "resource" : "Guideline Strength",
      "term" : "N/A",
      "termId" : "guidelineStrength:981501929",
      "version" : 1
    },
    "userId" : "rachel",
    "version" : 0
  }, {
    "@id" : "https://pharmgkb.org/dosingGuidelineAnnotationGroup/PA166244202",
    "@context" : "https://api.pharmgkb.org/jsonld/dosingGuidelineAnnotationGroup.jsonld",
    "objCls" : "Dosing Guideline Annotation Group",
    "id" : "PA166244202",
    "name" : "Activity Score 1.5",
    "activityScore" : {
      "id" : 1451447160,
      "html" : "<p>1.5</p>\n",
      "version" : 0
    },
    "genePhenotypes" : [ "DPYD:Decreased function/Normal function" ],
    "guideline" : {
      "@id" : "https://pharmgkb.org/guidelineAnnotation/PA166222801",
      "@context" : "https://api.pharmgkb.org/jsonld/guidelineAnnotation.jsonld",
      "objCls" : "Guideline Annotation",
      "id" : "PA166222801",
      "name" : "Annotation of DPWG Guideline for flucytosine and DPYD",
      "version" : 5
    },
    "implications" : {
      "id" : 1451447161,
      "html" : "<p>A very low risk of severe toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil. Patients with this gene variation are more likely to have a reaction to fluorouracil, but generally tolerate low doses (50-75% of the standard fluorouracil dose).</p>\n",
      "version" : 0
    },
    "phenotype" : {
      "id" : 1451447162,
      "html" : "<p>Carrier of one variant associated with reduced functionality of DPD activity</p>\n",
      "version" : 0
    },
    "recommendation" : {
      "id" : 1451447163,
      "html" : "<ul>\n<li>Be alert to the occurrence of severe side effects, such as leukopaenia, neutropaenia, thrombocytopaenia and diarrhoea\n<ul>\n<li>In the majority of cases, side effects of flucytosine occur in the first two to three weeks of the treatment. Flucytosine should be stopped if severe side effects occur.</li>\n</ul>\n</li>\n</ul>\n",
      "version" : 0
    },
    "rxChangeStatus" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/rxChange/rxChange:1448602496",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 1448602496,
      "parents" : [ ],
      "resource" : "Prescribing Change",
      "term" : "Possibly",
      "termId" : "rxChange:1448602496",
      "version" : 0
    },
    "strength" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 981501929,
      "description" : "Not Applicable",
      "parents" : [ ],
      "resource" : "Guideline Strength",
      "term" : "N/A",
      "termId" : "guidelineStrength:981501929",
      "version" : 1
    },
    "userId" : "rachel",
    "version" : 0
  }, {
    "@id" : "https://pharmgkb.org/dosingGuidelineAnnotationGroup/PA166244182",
    "@context" : "https://api.pharmgkb.org/jsonld/dosingGuidelineAnnotationGroup.jsonld",
    "objCls" : "Dosing Guideline Annotation Group",
    "id" : "PA166244182",
    "name" : "Activity Score PHENO",
    "activityScore" : {
      "id" : 1451447168,
      "html" : "<p>DPD enzyme activity cannot be predicted correctly, an additional phenotyping test is required to determine the DPD enzyme activity.</p>\n",
      "version" : 0
    },
    "genePhenotypes" : [ "DPYD:Decreased function/Decreased function", "DPYD:Decreased function/No function" ],
    "guideline" : {
      "@id" : "https://pharmgkb.org/guidelineAnnotation/PA166222801",
      "@context" : "https://api.pharmgkb.org/jsonld/guidelineAnnotation.jsonld",
      "objCls" : "Guideline Annotation",
      "id" : "PA166222801",
      "name" : "Annotation of DPWG Guideline for flucytosine and DPYD",
      "version" : 5
    },
    "implications" : {
      "id" : 1451447169,
      "html" : "<p>A very low risk of severe toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil. Patients with this gene variation are more likely to have a reaction to fluorouracil, but generally tolerate low doses (15-50% of the standard fluorouracil dose).</p>\n",
      "version" : 0
    },
    "phenotype" : {
      "id" : 1451447170,
      "html" : "<p>Carrier of two variants associated with reduced functionality of DPD activity OR carrier of one variant associated with reduced functionality of DPD activity and one variant associated with fully dysfunctional DPD activity</p>\n",
      "version" : 0
    },
    "recommendation" : {
      "id" : 1451447171,
      "html" : "<ul>\n<li>Be alert to the occurrence of severe side effects, such as leukopaenia, neutropaenia, thrombocytopaenia and diarrhoea.\n<ul>\n<li>In the majority of cases, side effects of flucytosine occur in the first two to three weeks of the treatment. Flucytosine should be stopped if severe side effects occur.</li>\n</ul>\n</li>\n</ul>\n",
      "version" : 0
    },
    "rxChangeStatus" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/rxChange/rxChange:1448602496",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 1448602496,
      "parents" : [ ],
      "resource" : "Prescribing Change",
      "term" : "Possibly",
      "termId" : "rxChange:1448602496",
      "version" : 0
    },
    "strength" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 981501929,
      "description" : "Not Applicable",
      "parents" : [ ],
      "resource" : "Guideline Strength",
      "term" : "N/A",
      "termId" : "guidelineStrength:981501929",
      "version" : 1
    },
    "userId" : "rachel",
    "version" : 0
  }, {
    "@id" : "https://pharmgkb.org/dosingGuidelineAnnotationGroup/PA166244201",
    "@context" : "https://api.pharmgkb.org/jsonld/dosingGuidelineAnnotationGroup.jsonld",
    "objCls" : "Dosing Guideline Annotation Group",
    "id" : "PA166244201",
    "name" : "Activity Score 1",
    "activityScore" : {
      "id" : 1451447172,
      "html" : "<p>1</p>\n",
      "version" : 0
    },
    "genePhenotypes" : [ "DPYD:No function/Normal function" ],
    "guideline" : {
      "@id" : "https://pharmgkb.org/guidelineAnnotation/PA166222801",
      "@context" : "https://api.pharmgkb.org/jsonld/guidelineAnnotation.jsonld",
      "objCls" : "Guideline Annotation",
      "id" : "PA166222801",
      "name" : "Annotation of DPWG Guideline for flucytosine and DPYD",
      "version" : 5
    },
    "implications" : {
      "id" : 1451447173,
      "html" : "<p>A very low risk of severe toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil. Patients with this gene variation are more likely to react to fluorouracil, but generally tolerate low doses (approximately 50% of the standard fluorouracil dose).</p>\n",
      "version" : 0
    },
    "phenotype" : {
      "id" : 1451447174,
      "html" : "<p>Carrier of one variant associated with fully dysfunctional DPD activity.</p>\n",
      "version" : 0
    },
    "recommendation" : {
      "id" : 1451447175,
      "html" : "<ul>\n<li>Be alert to the occurrence of severe side effects, such as leukopaenia, neutropaenia, thrombocytopaenia and diarrhoea\n<ul>\n<li>In the majority of cases, side effects of flucytosine occur in the first two to three weeks of the treatment. Flucytosine should be stopped if severe side effects occur</li>\n</ul>\n</li>\n</ul>\n",
      "version" : 0
    },
    "rxChangeStatus" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/rxChange/rxChange:1448602497",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 1448602497,
      "parents" : [ ],
      "resource" : "Prescribing Change",
      "term" : "Yes",
      "termId" : "rxChange:1448602497",
      "version" : 0
    },
    "strength" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 981501929,
      "description" : "Not Applicable",
      "parents" : [ ],
      "resource" : "Guideline Strength",
      "term" : "N/A",
      "termId" : "guidelineStrength:981501929",
      "version" : 1
    },
    "userId" : "rachel",
    "version" : 0
  }, {
    "@id" : "https://pharmgkb.org/dosingGuidelineAnnotationGroup/PA166244181",
    "@context" : "https://api.pharmgkb.org/jsonld/dosingGuidelineAnnotationGroup.jsonld",
    "objCls" : "Dosing Guideline Annotation Group",
    "id" : "PA166244181",
    "name" : "Activity Score 0",
    "activityScore" : {
      "id" : 1451447164,
      "html" : "<p>0</p>\n",
      "version" : 0
    },
    "genePhenotypes" : [ "DPYD:No function/No function" ],
    "guideline" : {
      "@id" : "https://pharmgkb.org/guidelineAnnotation/PA166222801",
      "@context" : "https://api.pharmgkb.org/jsonld/guidelineAnnotation.jsonld",
      "objCls" : "Guideline Annotation",
      "id" : "PA166222801",
      "name" : "Annotation of DPWG Guideline for flucytosine and DPYD",
      "version" : 5
    },
    "implications" : {
      "id" : 1451447165,
      "html" : "<p>A risk of life-threatening toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil and patients with this gene variation are intolerant even to small quantities of fluorouracil.</p>\n",
      "version" : 0
    },
    "phenotype" : {
      "id" : 1451447166,
      "html" : "<p>Carrier of two variants associated with fully dysfunctional DPD activity</p>\n",
      "version" : 0
    },
    "recommendation" : {
      "id" : 1451447167,
      "html" : "<p>Avoid flucytosine</p>\n",
      "version" : 0
    },
    "rxChangeStatus" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/rxChange/rxChange:1448602495",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 1448602495,
      "parents" : [ ],
      "resource" : "Prescribing Change",
      "term" : "No",
      "termId" : "rxChange:1448602495",
      "version" : 0
    },
    "strength" : {
      "@id" : "https://pharmgkb.org/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
      "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
      "id" : 981501929,
      "description" : "Not Applicable",
      "parents" : [ ],
      "resource" : "Guideline Strength",
      "term" : "N/A",
      "termId" : "guidelineStrength:981501929",
      "version" : 1
    },
    "userId" : "rachel",
    "version" : 0
  } ],
  "citations" : [ ],
  "guideline" : {
    "@id" : "https://pharmgkb.org/guidelineAnnotation/PA166222801",
    "@context" : "https://api.pharmgkb.org/jsonld/guidelineAnnotation.jsonld",
    "objCls" : "Guideline Annotation",
    "id" : "PA166222801",
    "name" : "Annotation of DPWG Guideline for flucytosine and DPYD",
    "cancerGenome" : false,
    "crossReferences" : [ ],
    "guidelineGenes" : [ {
      "id" : 1451446700,
      "alleles" : [ {
        "id" : 1451446701,
        "_label" : "Reference",
        "function" : {
          "@id" : "https://pharmgkb.org/ontologyTerm/alleleFunction/haplotypeTags:1445558335",
          "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
          "id" : 1445558335,
          "parents" : [ ],
          "resource" : "Allele Function",
          "term" : "Normal function",
          "termId" : "haplotypeTags:1445558335",
          "version" : 1
        },
        "haplotype" : {
          "@id" : "https://pharmgkb.org/haplotype/PA166171116",
          "@context" : "https://api.pharmgkb.org/jsonld/haplotype.jsonld",
          "objCls" : "Haplotype",
          "id" : "PA166171116",
          "symbol" : "DPYD Reference",
          "name" : "Reference",
          "version" : 10
        },
        "version" : 0
      }, {
        "id" : 1451446704,
        "_label" : "c.1129-5923C>G, c.1236G>A (HapB3)",
        "function" : {
          "@id" : "https://pharmgkb.org/ontologyTerm/alleleFunction/haplotypeTags:1445558331",
          "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
          "id" : 1445558331,
          "parents" : [ ],
          "resource" : "Allele Function",
          "term" : "Decreased function",
          "termId" : "haplotypeTags:1445558331",
          "version" : 1
        },
        "haplotype" : {
          "@id" : "https://pharmgkb.org/haplotype/PA166171120",
          "@context" : "https://api.pharmgkb.org/jsonld/haplotype.jsonld",
          "objCls" : "Haplotype",
          "id" : "PA166171120",
          "symbol" : "DPYD c.1129-5923C>G, c.1236G>A (HapB3)",
          "name" : "c.1129-5923C>G, c.1236G>A (HapB3)",
          "version" : 11
        },
        "version" : 0
      }, {
        "id" : 1451446702,
        "_label" : "c.1679T>G (*13)",
        "function" : {
          "@id" : "https://pharmgkb.org/ontologyTerm/alleleFunction/haplotypeTags:1445558515",
          "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
          "id" : 1445558515,
          "parents" : [ ],
          "resource" : "Allele Function",
          "term" : "No function",
          "termId" : "haplotypeTags:1445558515",
          "version" : 1
        },
        "haplotype" : {
          "@id" : "https://pharmgkb.org/haplotype/PA166171118",
          "@context" : "https://api.pharmgkb.org/jsonld/haplotype.jsonld",
          "objCls" : "Haplotype",
          "id" : "PA166171118",
          "symbol" : "DPYD c.1679T>G (*13)",
          "name" : "c.1679T>G (*13)",
          "version" : 11
        },
        "version" : 0
      }, {
        "id" : 1451446705,
        "_label" : "c.1905+1G>A, IVS14+1G>A (*2A)",
        "allele" : "c.1905+1G>A, IVS14+1G>A (*2A)",
        "function" : {
          "@id" : "https://pharmgkb.org/ontologyTerm/alleleFunction/haplotypeTags:1445558515",
          "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
          "id" : 1445558515,
          "parents" : [ ],
          "resource" : "Allele Function",
          "term" : "No function",
          "termId" : "haplotypeTags:1445558515",
          "version" : 1
        },
        "version" : 0
      }, {
        "id" : 1451446703,
        "_label" : "c.2846A>T",
        "function" : {
          "@id" : "https://pharmgkb.org/ontologyTerm/alleleFunction/haplotypeTags:1445558331",
          "@context" : "https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld",
          "id" : 1445558331,
          "parents" : [ ],
          "resource" : "Allele Function",
          "term" : "Decreased function",
          "termId" : "haplotypeTags:1445558331",
          "version" : 1
        },
        "haplotype" : {
          "@id" : "https://pharmgkb.org/haplotype/PA166171119",
          "@context" : "https://api.pharmgkb.org/jsonld/haplotype.jsonld",
          "objCls" : "Haplotype",
          "id" : "PA166171119",
          "symbol" : "DPYD c.2846A>T",
          "name" : "c.2846A>T",
          "version" : 10
        },
        "version" : 0
      } ],
      "gene" : {
        "@id" : "https://pharmgkb.org/gene/PA145",
        "@context" : "https://api.pharmgkb.org/jsonld/gene.jsonld",
        "objCls" : "Gene",
        "id" : "PA145",
        "symbol" : "DPYD",
        "name" : "dihydropyrimidine dehydrogenase",
        "altNames" : {
          "symbol" : [ "DPD" ]
        },
        "buildVersion" : "GRCh38.p7",
        "cbStart" : "p21.3",
        "cbStop" : "p21.3",
        "chr" : {
          "@id" : "https://pharmgkb.org/chromosome/PA503",
          "@context" : "https://api.pharmgkb.org/jsonld/chromosome.jsonld",
          "objCls" : "Chromosome",
          "id" : "PA503",
          "name" : "chr1",
          "version" : 3
        },
        "chrStartPosB37" : 97543299,
        "chrStartPosB38" : 97077743,
        "chrStopPosB37" : 98386615,
        "chrStopPosB38" : 97921059,
        "cpicGene" : true,
        "crossReferences" : [ {
          "@id" : "https://pharmgkb.org/crossReference/alfred/LO003560O",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 560574648,
          "resource" : "ALFRED",
          "resourceId" : "LO003560O",
          "_url" : "http://alfred.med.yale.edu/alfred/recordinfop.asp?UNID=LO003560O",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/ctd/1806",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 553241004,
          "resource" : "Comparative Toxicogenomics Database",
          "resourceId" : "1806",
          "_url" : "http://ctdbase.org/detail.go?type=gene&acc=1806",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/ensembl/ENSG00000188641",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 132256781,
          "resource" : "Ensembl",
          "resourceId" : "ENSG00000188641",
          "_url" : "http://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000188641",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/genAtlas/DPYD",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 73824,
          "resource" : "GenAtlas",
          "resourceId" : "DPYD",
          "_url" : "http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=DPYD",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/geneCard/DPYD",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 88752,
          "resource" : "GeneCard",
          "resourceId" : "DPYD",
          "_url" : "http://www.genecards.org/cgi-bin/carddisp.pl?gene=DPYD",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0004152",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 36328,
          "resource" : "GO",
          "resourceId" : "GO:0004152",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0004152",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0004158",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 8680499,
          "resource" : "GO",
          "resourceId" : "GO:0004158",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0004158",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0005506",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 34969,
          "resource" : "GO",
          "resourceId" : "GO:0005506",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0005506",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0005737",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 34650,
          "resource" : "GO",
          "resourceId" : "GO:0005737",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0005737",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0006118",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 35063,
          "resource" : "GO",
          "resourceId" : "GO:0006118",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0006118",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0006207",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 36417,
          "resource" : "GO",
          "resourceId" : "GO:0006207",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0006207",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0006212",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 62330381,
          "resource" : "GO",
          "resourceId" : "GO:0006212",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0006212",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0006214",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 62330391,
          "resource" : "GO",
          "resourceId" : "GO:0006214",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0006214",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0009055",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 77819322,
          "resource" : "GO",
          "resourceId" : "GO:0009055",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0009055",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0015036",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 8616501,
          "resource" : "GO",
          "resourceId" : "GO:0015036",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0015036",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0016020",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 34795,
          "resource" : "GO",
          "resourceId" : "GO:0016020",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0016020",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0017113",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 62330382,
          "resource" : "GO",
          "resourceId" : "GO:0017113",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0017113",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0046872",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 746292,
          "resource" : "GO",
          "resourceId" : "GO:0046872",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0046872",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/go/GO:0051539",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 123071530,
          "resource" : "GO",
          "resourceId" : "GO:0051539",
          "_url" : "http://amigo.geneontology.org/amigo/term/GO%3A0051539",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/hgnc/HGNC:3012",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 608166378,
          "resource" : "HGNC",
          "resourceId" : "HGNC:3012",
          "_url" : "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC%3A3012",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/HumanCycGene/HS06975",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 608166386,
          "resource" : "HumanCyc Gene",
          "resourceId" : "HS06975",
          "_url" : "http://biocyc.org/HUMAN/NEW-IMAGE?object=HS06975",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/modBase/Q12882",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 560885045,
          "resource" : "ModBase",
          "resourceId" : "Q12882",
          "_url" : "http://salilab.org/modbase/search?modelflag=longest&databaseID=Q12882",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/mutDb/DPYD",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 456362,
          "resource" : "MutDB",
          "resourceId" : "DPYD",
          "_url" : "http://www.mutdb.org/genes/search?_method=POST&data%5BSearch%5D%5Bidentifier%5D=DPYD",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/entrezGene/1806",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 11131,
          "resource" : "NCBI Gene",
          "resourceId" : "1806",
          "_url" : "https://www.ncbi.nlm.nih.gov/gene/1806",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/omim/274270",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 2866,
          "resource" : "OMIM",
          "resourceId" : "274270",
          "_url" : "http://omim.org/entry/274270",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/omim/612779",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 608166384,
          "resource" : "OMIM",
          "resourceId" : "612779",
          "_url" : "http://omim.org/entry/612779",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/pharmVarGene/DPYD",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 1451280334,
          "resource" : "PharmVar Gene",
          "resourceId" : "DPYD",
          "_url" : "https://www.pharmvar.org/gene/DPYD",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/refSeqDna/NG_008807",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 560574649,
          "resource" : "RefSeq DNA",
          "resourceId" : "NG_008807",
          "_url" : "https://www.ncbi.nlm.nih.gov/nuccore/NG_008807",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/refSeqDna/NT_032977",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 37071,
          "resource" : "RefSeq DNA",
          "resourceId" : "NT_032977",
          "_url" : "https://www.ncbi.nlm.nih.gov/nuccore/NT_032977",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/refSeqProtein/NP_000101",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 37281,
          "resource" : "RefSeq Protein",
          "resourceId" : "NP_000101",
          "_url" : "https://www.ncbi.nlm.nih.gov/nuccore/NP_000101",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/refSeqProtein/NP_001153773",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 608166383,
          "resource" : "RefSeq Protein",
          "resourceId" : "NP_001153773",
          "_url" : "https://www.ncbi.nlm.nih.gov/nuccore/NP_001153773",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/refSeqRna/NM_000110",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 46356,
          "resource" : "RefSeq RNA",
          "resourceId" : "NM_000110",
          "_url" : "https://www.ncbi.nlm.nih.gov/nuccore/NM_000110",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/refSeqRna/NM_001160301",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 608166382,
          "resource" : "RefSeq RNA",
          "resourceId" : "NM_001160301",
          "_url" : "https://www.ncbi.nlm.nih.gov/nuccore/NM_001160301",
          "version" : 0
        }, {
          "@id" : "https://pharmgkb.org/crossReference/ucscGenomeBrowser/NM_000110",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 121673,
          "resource" : "UCSC Genome Browser",
          "resourceId" : "NM_000110",
          "_url" : "http://genome.ucsc.edu/cgi-bin/hgTracks?Submit=Submit&position=NM_000110",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/uniProtKb/Q12882",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 62330367,
          "name" : "DPYD_HUMAN",
          "resource" : "UniProtKB",
          "resourceId" : "Q12882",
          "_url" : "http://www.uniprot.org/uniprot/Q12882",
          "version" : 1
        }, {
          "@id" : "https://pharmgkb.org/crossReference/uniProtKb/Q96HL6",
          "@context" : "https://api.pharmgkb.org/jsonld/crossReference.jsonld",
          "id" : 608166385,
          "name" : "Q96HL6_HUMAN",
          "resource" : "UniProtKB",
          "resourceId" : "Q96HL6",
          "_url" : "http://www.uniprot.org/uniprot/Q96HL6",
          "version" : 1
        } ],
        "hasNonStandardHaplotypes" : false,
        "hideHaplotypes" : true,
        "pharmVarGene" : true,
        "strand" : "minus",
        "terms" : [ {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0004158","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560498530,"_url":"http://amigo.geneontology.org/amigo/term/GO:0004158","resource":"Gene Ontology","term":"dihydroorotate oxidase activity","termId":"GO:0004158"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0004159","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560498531,"_url":"http://amigo.geneontology.org/amigo/term/GO:0004159","resource":"Gene Ontology","term":"dihydrouracil dehydrogenase (NAD+) activity","termId":"GO:0004159"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0005488","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560495048,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005488","resource":"Gene Ontology","term":"binding","termId":"GO:0005488"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0005506","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560499841,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005506","resource":"Gene Ontology","term":"iron ion binding","termId":"GO:0005506"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0005737","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500078,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005737","resource":"Gene Ontology","term":"cytoplasm","termId":"GO:0005737"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0005829","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500177,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005829","resource":"Gene Ontology","term":"cytosol","termId":"GO:0005829"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006145","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500566,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006145","resource":"Gene Ontology","term":"purine base catabolic process","termId":"GO:0006145"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006207","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500682,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006207","resource":"Gene Ontology","term":"'de novo' pyrimidine base biosynthetic process","termId":"GO:0006207"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006208","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500684,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006208","resource":"Gene Ontology","term":"pyrimidine base catabolic process","termId":"GO:0006208"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006210","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500687,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006210","resource":"Gene Ontology","term":"thymine catabolic process","termId":"GO:0006210"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006212","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500691,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006212","resource":"Gene Ontology","term":"uracil catabolic process","termId":"GO:0006212"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006214","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500695,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006214","resource":"Gene Ontology","term":"thymidine catabolic process","termId":"GO:0006214"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0006222","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560500709,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006222","resource":"Gene Ontology","term":"UMP biosynthetic process","termId":"GO:0006222"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0009055","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560503412,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009055","resource":"Gene Ontology","term":"electron carrier activity","termId":"GO:0009055"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0016491","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560495264,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016491","resource":"Gene Ontology","term":"oxidoreductase activity","termId":"GO:0016491"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0017113","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560507384,"_url":"http://amigo.geneontology.org/amigo/term/GO:0017113","resource":"Gene Ontology","term":"dihydropyrimidine dehydrogenase (NADP+) activity","termId":"GO:0017113"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0042803","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560513251,"_url":"http://amigo.geneontology.org/amigo/term/GO:0042803","resource":"Gene Ontology","term":"protein homodimerization activity","termId":"GO:0042803"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0046872","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560495445,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046872","resource":"Gene Ontology","term":"metal ion binding","termId":"GO:0046872"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0050660","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560520673,"_url":"http://amigo.geneontology.org/amigo/term/GO:0050660","resource":"Gene Ontology","term":"FAD binding","termId":"GO:0050660"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0050661","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560520674,"_url":"http://amigo.geneontology.org/amigo/term/GO:0050661","resource":"Gene Ontology","term":"NADP or NADPH binding","termId":"GO:0050661"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0051539","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560521260,"_url":"http://amigo.geneontology.org/amigo/term/GO:0051539","resource":"Gene Ontology","term":"4 iron, 4 sulfur cluster binding","termId":"GO:0051539"}, {"@id":"https://pharmgkb.org/ontologyTerm/GO/GO:0055114","@context":"https://api.pharmgkb.org/jsonld/ontologyTerm.jsonld","id":560509993,"_url":"http://amigo.geneontology.org/amigo/term/GO:0055114","resource":"Gene Ontology","term":"oxidation reduction","termId":"GO:0055114"} ],
        "version" : 6907
      },
      "version" : 0
    } ],
    "hasTestingGuidance" : true,
    "history" : [ {
      "id" : 1451257822,
      "date" : "2020-08-31T00:00:00-07:00",
      "type" : "Create",
      "version" : 0
    }, {
      "id" : 1451698047,
      "date" : "2022-02-28T14:49:52.771-08:00",
      "description" : "no change to recommendation text, updated the linked to the DPD:flucytosine pdf",
      "type" : "Update",
      "version" : 0
    }, {
      "id" : 1451704253,
      "date" : "2022-03-03T16:33:35.188-08:00",
      "description" : "Annotation current with May 2021 DPWG Guideline release",
      "type" : "Note",
      "version" : 0
    }, {
      "id" : 1451706940,
      "date" : "2022-03-08T08:12:06.503-08:00",
      "description" : "Added information about preemptive genotyping",
      "type" : "Update",
      "version" : 0
    }, {
      "id" : 1451732892,
      "date" : "2022-03-28T09:57:49.105-07:00",
      "description" : "Annotation current with February 2022 DPWG guideline release",
      "type" : "Note",
      "version" : 0
    }, {
      "id" : 1451733312,
      "date" : "2022-03-28T14:40:11.286-07:00",
      "description" : "Updated link to testing guidance page",
      "type" : "Update",
      "version" : 0
    }, {
      "id" : 1451741474,
      "date" : "2022-04-05T11:13:46.099-07:00",
      "description" : "Added testing guidance tag",
      "type" : "Update",
      "version" : 0
    } ],
    "literature" : [ {"@id":"https://pharmgkb.org/literature/15113882","@context":"https://api.pharmgkb.org/jsonld/literature.jsonld","id":15113882,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2020","_sameAs":"https://www.knmp.nl/downloads/pharmacogenetic-recommendations-august-2020.pdf","crossReferences":[{"@id":"https://pharmgkb.org/crossReference/url/https://www.knmp.nl/downloads/pharmacogenetic-recommendations-august-2020.pdf","@context":"https://api.pharmgkb.org/jsonld/crossReference.jsonld","id":1451257580,"resource":"URL","resourceId":"https://www.knmp.nl/downloads/pharmacogenetic-recommendations-august-2020.pdf","_url":"https://www.knmp.nl/downloads/pharmacogenetic-recommendations-august-2020.pdf"}],"objCls":"Literature"} ],
    "pediatric" : false,
    "recommendation" : true,
    "relatedAlleles" : [ ],
    "relatedChemicals" : [ {
      "@id" : "https://pharmgkb.org/chemical/PA449654",
      "@context" : "https://api.pharmgkb.org/jsonld/chemical.jsonld",
      "objCls" : "Chemical",
      "id" : "PA449654",
      "name" : "flucytosine",
      "version" : 5
    } ],
    "relatedGenes" : [ {
      "@id" : "https://pharmgkb.org/gene/PA145",
      "@context" : "https://api.pharmgkb.org/jsonld/gene.jsonld",
      "objCls" : "Gene",
      "id" : "PA145",
      "symbol" : "DPYD",
      "name" : "dihydropyrimidine dehydrogenase",
      "version" : 6907
    } ],
    "source" : "DPWG",
    "summaryMarkdown" : {
      "id" : 1451257820,
      "html" : "<p>The Dutch Pharmacogenetics Working Group Guideline for flucytosine states that patients with a DPYD activity score of 0 should avoid flucytosine. Patients with a DPYD activity score of 1 or 1.5 should be alert to the occurrence of severe side effects and flucytosine should be stopped if severe side effects occur.</p>\n",
      "version" : 0
    },
    "terms" : [ ],
    "textMarkdown" : {
      "id" : 1451257821,
      "html" : "<h3 id=\"august-2020\">August 2020</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for flucytosine based on DPYD activity score.</p>\n<p><em>Wording in table taken from <a download=\"DPWG_August_2020.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_August_2020.pdf\">Dutch guidelines August 2020 update</a></em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>DPD AS 0</td>\n<td>flucytosine</td>\n<td>A risk of life-threatening toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil and patients with this gene variation are intolerant even to small quantities of fluorouracil.</td>\n<td>Avoid flucytosine</td>\n</tr>\n<tr>\n<td>DPD AS 1</td>\n<td>flucytosine</td>\n<td>A very low risk of severe toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil. Patients with this gene variation are more likely to react to fluorouracil, but generally tolerate low doses (approximately 50% of the standard fluorouracil dose).</td>\n<td>Be alert to the occurrence of severe side effects, such as leukopaenia, neutropaenia, thrombocytopaenia and diarrhoea. In the majority of cases, side effects of flucytosine occur in the first two to three weeks of the treatment. Flucytosine should be stopped if severe side effects occur.</td>\n</tr>\n<tr>\n<td>DPD AS 1.5</td>\n<td>flucytosine</td>\n<td>A very low risk of severe toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil. Patients with this gene variation are more likely to have a reaction to fluorouracil, but generally tolerate low doses (50-75% of the standard fluorouracil dose).</td>\n<td>Be alert to the occurrence of severe side effects, such as leukopaenia, neutropaenia, thrombocytopaenia and diarrhoea. In the majority of cases, side effects of flucytosine occur in the first two to three weeks of the treatment. Flucytosine should be stopped if severe side effects occur.</td>\n</tr>\n<tr>\n<td>DPD FENO</td>\n<td>flucytosine</td>\n<td>A very low risk of severe toxicity is increased by gene variation. A small proportion of flucytosine is converted to fluorouracil. Patients with this gene variation are more likely to have a reaction to fluorouracil, but generally tolerate low doses (15-50% of the standard fluorouracil dose).</td>\n<td>Be alert to the occurrence of severe side effects, such as leukopaenia, neutropaenia, thrombocytopaenia and diarrhoea. In the majority of cases, side effects of flucytosine occur in the first two to three weeks of the treatment. Flucytosine should be stopped if severe side effects occur.</td>\n</tr>\n</tbody>\n</table>\n<h4 id=\"preemptive-genotyping\">Preemptive genotyping</h4>\n<p>Excerpts from the <a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0007209.PDF\" target=\"_blank\">DPWG risk analysis document</a> for flucytosine and DPYD:</p>\n<blockquote class=\"blockquote\">\n<p>The KNMP Pharmacogenetics Working Group considers genotyping before starting flucytosine to be beneficial for drug safety. It is advised to genotype these patients before (or directly after) drug therapy has been initiated to guide drug selection.</p>\n</blockquote>\n<p><a href=\"/page/testingGuidance\">Read more about how DPWG assigns their recommendations for preemptive genotyping.</a></p>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0007211.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a rel=\"noopener noreferrer\" href=\"https://www.knmp.nl/producten/gebruiksrecht-g-standaard/medicatiebewaking-g-standaard/background-information-pharmacogenetics\" target=\"_blank\">Read about gene information from DPWG</a></p>\n",
      "version" : 2
    },
    "userId" : "katrin",
    "version" : 5
  }
}